Oxtellar XR 150 mg 24HR Extended Release Oral Tablet, Once-Daily
RxNorm 1365660
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1365660 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Oxtellar XR 150 mg 24HR Extended Release Oral Tablet, Once-Daily.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
24 HR oxcarbazepine 150 mg Extended Release Oral Tablet [Oxtellar]
(Atom ID: 6347450)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
24 HR OXcarbazepine 150 mg Extended Release Oral Tablet [Oxtellar]
(Atom ID: 6377818)
SYPrescribable
Synonym (SY):
24 HR Oxtellar 150 mg Extended Release Oral Tablet
(Atom ID: 6356693)
SYPrescribable
Synonym (SY):
Oxtellar XR 150 mg 24 HR Extended Release Oral Tablet
(Atom ID: 6357016)
PSNPrescribable
Prescribable Name (PSN):
Oxtellar XR 150 mg 24HR Extended Release Oral Tablet, Once-Daily
(Atom ID: 6362830)
Patient Education
Oxcarbazepine
Oxcarbazepine (Trileptal) is used alone or in combination with other medications to control certain types of seizures in adults and children. Oxcarbazepine extended-release tablets (Oxtellar XR) are used in combination with other medications to control certain types of seizures in adults and children 6 years of age and older. Oxcarbazepine is in a class of medications called anticonvulsants. It works by decreasing abnormal electrical activity in the brain.
[Learn More]
* Please review the disclaimer below.